MILLIPRED DP (prednisolone)
TRICHINOSIS·+59
LASER PHARMACEU
Indication
Primary adrenocortical insufficiency
Primary adrenocortical insufficiency is an endocrine disorder characterized by structural destruction or dysfunction of the adrenal cortex, preventing adequate endogenous production of glucocorticoids and mineralocorticoids. Read more about Primary adrenocortical insufficiency
214 drugs 115 manufacturers
Drugs that treat it
Common Primary adrenocortical insufficiency therapies.
PREDNISONE
GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
CADISTA PHARMAC
PREDNISONE
PULMONARY TUBERCULOSIS·+67
QUALITEST
PREDNISOLONE SODIUM PHOSPHATE
TRICHINOSIS·+59
HI-TECH PHARMAC
PREDNISOLONE SODIUM PHOSPHATE
TRICHINOSIS·+59
UPSTATE PHARMA
METHYLPREDNISOLONE
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+55
GREENSTONE LLC.
METHYLPREDNISOLONE
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+55
CADISTA PHARMAC
METHYLPREDNISOLONE
DISSEMINATED TUBERCULOSIS·+55
QUALITEST
SOLU-MEDROL (methylprednisolone sodium succinate/PF)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+52
Laboratories Div
Filter & compare in the drug finder →Opens the drug finder with Primary adrenocortical insufficiency preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrimary adrenocortical insufficiency is an endocrine disorder characterized by structural destruction or dysfunction of the adrenal cortex, preventing adequate endogenous production of glucocorticoids and mineralocorticoids.
Most commonly caused by autoimmune adrenalitis (Addison disease), infections, or genetic conditions, it can affect individuals of any age or sex.
Pathophysiologically, the resulting deficit in cortisol and aldosterone leads to compensatory elevations in adrenocorticotropic hormone (ACTH) and plasma renin activity.
Defining clinical features include chronic fatigue, anorexia, weight loss, orthostatic hypotension, cutaneous hyperpigmentation, hyponatremia, and hyperkalemia, with the potential to progress to life-threatening acute adrenal crisis.
- nih.gov
Primary adrenocortical insufficiency is an endocrine disorder characterized by structural destruction or dysfunction of the adrenal cortex, preventing adequate endogenous production of glucocorticoids and mineralocorticoids Most commonly caused by autoimmune adrenalitis (Addison disease), infections, or genetic conditions, it can affect individuals of any age or sex
- nih.gov
Primary adrenocortical insufficiency is an endocrine disorder characterized by structural destruction or dysfunction of the adrenal cortex, preventing adequate endogenous production of glucocorticoids and mineralocorticoids
- pharmaceutical-journal.com
Most commonly caused by autoimmune adrenalitis (Addison disease), infections, or genetic conditions, it can affect individuals of any age or sex
- mayoclinic.org
Most commonly caused by autoimmune adrenalitis (Addison disease), infections, or genetic conditions, it can affect individuals of any age or sex Defining clinical features include chronic fatigue, anorexia, weight loss, orthostatic hypotension, cutaneous hyperpigmentation, hyponatremia, and hyperkalemia, with the potential to progress to life-threatening acute adrenal crisis
- nih.gov
Defining clinical features include chronic fatigue, anorexia, weight loss, orthostatic hypotension, cutaneous hyperpigmentation, hyponatremia, and hyperkalemia, with the potential to progress to life-threatening acute adrenal crisis
Personalize your experience
Follow Primary adrenocortical insufficiency and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.